Eden Research PLC on Tuesday celebrated the grant of regulatory authorisation for use of its flagship biofungicide, Mevalone, in Germany.

Mevalone is authorised for professional use on grapevines and apples to control Botrytis on grapes and for the prevention of storage diseases on apples.

Oxfordshire, England-based Eden Research develops sustainable biopesticides and plastic-free formulation technologies for use in the global crop protection, animal health and consumer products industries.

The company highlights that Germany is the fourth largest wine-producing country in Europe and has 13 designated wine regions accounting for a total area of 103,000 hectares.

Further, Germany harvest more than 1.1 million tonnes of apples per year. ‘Apples are one of the most intensive crops in terms of preventative fungicide applications, but there is still the need to reduce their load of fungi in the fruit during long cold storage periods. In this case, Mevalone will prolong these storage periods without the need of additional conventional fungicides,’ Eden Research said.

Chief Executive Officer Sean Smith said: ‘In the context of our EU addressable market, Germany is a particularly notable territory gain for Eden and Mevalone given the prevalence of fungal disease in the cooler conditions in which wine grapes and apples are grown. It is also encouraging to note the German regulator’s support for products such as Mevalone as, like growers across Europe and the UK, German farmers are increasingly challenged by the removal of conventional pesticides from the market.’

Eden Research shares rose 9.2% to 4.53 pence each on Tuesday afternoon in London.

Copyright 2024 Alliance News Ltd. All Rights Reserved.